Novel Indenoisoquinolone CMYC/TOPOISOMERASE 1 Inhibitor (LMP744) in Recurrent Glioblastoma
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Clinical Trials Related to Brain and Central Nervous System Tumors
Related studies linked through entity extraction aliases.
Study of MT027 in Patients with Brain, Meninges, and Spinal Cord Metastatic Solid Tumors
- Status
- NOT_YET_RECRUITING
- Phase
- PHASE1
AXL Inhibitor BGB324 in Treating Participants With Recurrent Glioblastoma Undergoing Surgery
- Status
- TERMINATED
- Phase
- EARLY_PHASE1
Study of GDC-0084 in Pediatric Patients With Newly Diagnosed Diffuse Intrinsic Pontine Glioma or Diffuse Midline Gliomas
- Status
- COMPLETED
- Phase
- PHASE1
A Study Assessing Pamiparib With Radiation and/or Temozolomide (TMZ) in Participants With Newly Diagnosed or Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Studying Gene Expression and Location in Samples From Patients With Brain Tumors
- Status
- COMPLETED
- Phase
- N/A
Studying Gene Expression in Samples From Patients With Rhabdoid Tumors
- Status
- COMPLETED
- Phase
- N/A
Mibefradil Dihydrochloride and Temozolomide in Treating Patients With Recurrent Glioma
- Status
- COMPLETED
- Phase
- PHASE1
Olaparib and Temozolomide in Treating Patients With Relapsed Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1
Modafinil in Treating Children With Memory and Attention Problems Caused by Cancer Treatment for a Brain Tumor
- Status
- COMPLETED
- Phase
- PHASE2
Gene Mutation in Samples From Young Patients With Pleuropulmonary Blastoma Syndrome at Risk for Developing Cancer
- Status
- COMPLETED
- Phase
- N/A
Imetelstat Sodium in Treating Young Patients With Refractory or Recurrent Solid Tumors or Lymphoma
- Status
- COMPLETED
- Phase
- PHASE1
Boron Phenylalanine With or Without Mannitol in Treating Patients With Glioblastoma Multiforme
- Status
- TERMINATED
- Phase
- PHASE1
Biomarkers in Blood Samples From Young Patients With Newly Diagnosed Brain Tumors Undergoing Standard Radiation Therapy and Chemotherapy
- Status
- WITHDRAWN
- Phase
- NA
Vaccine Therapy, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1
Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma
- Status
- TERMINATED
- Phase
- PHASE1
High-Dose Chemotherapy and Stem Cell Transplant in Treating Patients With Metastatic Germ Cell Tumors That Have Not Responded to First-Line Therapy
- Status
- UNKNOWN
- Phase
- PHASE2
PTC299 in Treating Young Patients With Refractory or Recurrent Primary Central Nervous System Tumors
- Status
- COMPLETED
- Phase
- PHASE1
Everolimus, Temozolomide, and Radiation Therapy in Treating Patients With Newly Diagnosed Glioblastoma Multiforme
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2
Veliparib and Temozolomide in Treating Patients With Recurrent Glioblastoma
- Status
- COMPLETED
- Phase
- PHASE1/PHASE2